Identifying harmful flavor chemicals in e-cigarettes
Systematic identification of cardiotoxic e-cigarette flavorants
This study is looking at how different flavors in e-cigarettes might affect your heart health, especially if you use them regularly, to help understand any risks that come with vaping flavored e-liquids.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-11061112 on NIH RePORTER |
What this research studies
This research investigates the effects of various flavoring chemicals used in e-cigarettes on heart health. By examining how these flavorants interact with nicotine and affect heart function, the study aims to uncover potential risks associated with e-cigarette use. The researchers will use advanced techniques to analyze changes in heart activity, particularly focusing on arrhythmias and other cardiac issues that may arise from inhaling flavored e-cigarette aerosols. The findings could provide valuable insights into the safety of e-cigarette flavors for users.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals under 21 who use e-cigarettes and may be at risk for cardiac issues.
Not a fit: Patients who do not use e-cigarettes or are over the age of 21 may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and regulation of e-cigarette flavorants, potentially reducing the risk of heart-related issues for users.
How similar studies have performed: While there is ongoing research into the effects of nicotine on heart health, the specific investigation of e-cigarette flavorants is relatively novel and has not been extensively tested.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Carll, Alex Perrow — University of Louisville
- Study coordinator: Carll, Alex Perrow
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.